Veradigm (NASDAQ:MDRX) Shares Climb 4.7% – Still a Buy?

Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s share price was up 4.7% on Thursday. The stock traded as high as $4.9750 and last traded at $4.9750. Approximately 1,194 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 117,638 shares. The stock had previously closed at $4.75.

Veradigm Trading Up 4.7%

The company’s 50 day simple moving average is $4.87 and its 200-day simple moving average is $4.76. The company has a market capitalization of $608.44 million, a price-to-earnings ratio of 23.25 and a beta of 0.50.

Veradigm Company Profile

(Get Free Report)

Veradigm is a healthcare technology company that develops software and data solutions for medical practices, health systems, payers and life sciences organizations. Its offerings include electronic health record and practice-management tools, revenue-cycle services, and technology for coordinating care and managing clinical and administrative workflows. The company also provides data and analytics products that help healthcare organizations and life sciences companies support research, understand patient populations and inform decisions.

See Also

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.